The FDA approved the first-ever GLP-1 pill for obesity from Novo Nordisk, a move expected to expand access for patients who prefer pills over injections.
A board, appointed by President Donald Trump, voted to rename Washington’s performing arts venue the “Trump Kennedy Center,” immediately updating its branding.
Eli Lilly said its experimental daily obesity pill helped patients maintain most of their weight loss after switching from injectable drugs like Zepbound.
Democratic senators sharply criticized FCC Chairman Brendan Carr, accusing him of politicizing the agency by pressuring broadcasters over Jimmy Kimmel’s show.
Four moderate House Republicans broke with Speaker Mike Johnson and joined Democrats to force a vote on extending enhanced Obamacare subsidies set to expire.
